The Frequencies of Gastroesophageal and Extragastroesophageal Symptoms in Patients with Mild Erosive Esophagitis, Severe Erosive Esophagitis, and Barrett’s Esophagus in Taiwan
Background. Gastroesophageal reflux disease (GERD) may present with gastroesophageal and extraesophageal symptoms. Currently, the frequencies of gastroesophageal and extragastroesophageal symptoms in Asian patients with different categories of GERD remain unclear. Aim. To investigate the frequencies of gastroesophageal and extragastroesophageal symptoms in patients with mild erosive esophagitis, severe erosive esophagitis, and Barrett’s esophagus of GERD. Methods. The symptoms of symptomatic subjects with (1) Los Angeles grade A/B erosive esophagitis, (2) Los Angeles grade C/D erosive esophagitis, and (3) Barrett’s esophagus proven by endoscopy were prospectively assessed by a standard questionnaire for gastroesophageal and extragastroesophageal symptoms. The frequencies of the symptoms were compared by Chi-square test. Result. Six hundred and twenty-five patients (LA grade A/B: 534 patients; LA grade C/D: 37 patients; Barrett’s esophagus: 54 patients) were assessed for gastroesophageal and extragastroesophageal symptoms. Patients with Los Angeles grade A/B erosive esophagitis had higher frequencies of symptoms including epigastric pain, epigastric fullness, dysphagia, and throat cleaning than patients with Los Angeles grade C/D erosive esophagitis. Patients with Los Angeles grade A/B erosive esophagitis also had higher frequencies of symptoms including acid regurgitation, epigastric acidity, regurgitation of food, nausea, vomiting, epigastric fullness, dysphagia, foreign body sensation of throat, throat cleaning, and cough than patients with Barrett’s esophagus. Conclusion. The frequencies of some esophageal and extraesophageal symptoms in patients with Los Angeles grade A/B erosive esophagitis were higher than those in patients with Los Angeles grade C/D erosive esophagitis and Barrett’s esophagus. The causes of different symptom profiles in different categories of GERD patients merit further investigations. 1. Introduction The Montreal Definition and Classification of Gastroesophageal Reflux Disease defines GERD as a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications [1]. Gastroesophageal reflux occurs when there is a transient decrease in tension in the lower esophageal sphincter, allowing gastric contents to leak into the esophagus [2]. In most people with GERD, gastric juice reflux causes heartburn, as a painful or burning sensation in the esophagus, but regurgitation of digestive juices is also common [3]. Other than two classic reflux symptoms above, dysphagia is reported by more than
References
[1]
N. Vakil, S. V. Van Zanten, P. Kahrilas et al., “The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus,” American Journal of Gastroenterology, vol. 101, no. 8, pp. 1900–1943, 2006.
[2]
J. Dent, “Patterns of lower esophageal sphincter function associated with gastroesophageal reflux,” American Journal of Medicine, vol. 103, no. 5 A, pp. 29S–32S, 1997.
[3]
P. Malfertheiner and B. Hallerb？ck, “Clinical manifestations and complications of gastroesophageal reflux disease (GERD),” International Journal of Clinical Practice, vol. 59, no. 3, pp. 346–355, 2005.
[4]
P. Jacob, P. J. Kahrilas, and A. Vanagunas, “Peristaltic dysfunction associated with nonobstructive dysphagia in reflux disease,” Digestive Diseases and Sciences, vol. 35, no. 8, pp. 939–942, 1990.
[5]
R. J. Brzana and K. L. Koch, “Gastroesophageal reflux disease presenting with intractable nausea,” Annals of Internal Medicine, vol. 126, no. 9, pp. 704–707, 1997.
[6]
D. Jaspersen, M. Kulig, J. Labenz et al., “Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study,” Alimentary Pharmacology and Therapeutics, vol. 17, no. 12, pp. 1515–1520, 2003.
[7]
F.-W. Wang, M.-S. Tu, H.-Y. Chuang, H.-C. Yu, L.-C. Cheng, and P.-I. Hsu, “Erosive esophagitis in asymptomatic subjects: risk factors,” Digestive Diseases and Sciences, vol. 55, no. 5, pp. 1320–1324, 2010.
[8]
D. A. Johnson and M. B. Fennerty, “Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease,” Gastroenterology, vol. 126, no. 3, pp. 660–664, 2004.
[9]
A. J. Bredenoord, G. J. M. Hemmink, and A. J. P. M. Smout, “Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage,” Neurogastroenterology and Motility, vol. 21, no. 8, pp. 807–812, 2009.
[10]
D. Levine, B. Hamelin, D. Magner, P. Rogers, R. Barret, and B. Joelsson, “Correlation between patient demographics and heartburn severity with Los Angeles (LA) classification of erosive esophagitis,” The American Journal of Gastroenterology, vol. 94, p. 2591, 1999.
[11]
A. J. P. M. Smout, “Endoscopy-negative acid reflux disease,” Alimentary Pharmacology and Therapeutics, Supplement, vol. 11, no. 2, pp. 81–85, 1997.
[12]
R. Carlsson, J. Dent, R. Watts et al., “Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole,” European Journal of Gastroenterology and Hepatology, vol. 10, no. 2, pp. 119–124, 1998.
[13]
T. K. Cheung, W. M. Wong, N. Y. H. Wong et al., “Symptom resolution does not predict healing of erosive oesophagitis in Chinese,” Digestion, vol. 75, no. 2-3, pp. 128–134, 2007.
[14]
G. W. Falk, “Gastroesophageal reflux disease and Barrett's esophagus,” Endoscopy, vol. 33, no. 2, pp. 109–118, 2001.
[15]
J. Ronkainen, P. Aro, T. Storskrubb et al., “Prevalence of Barrett's esophagus in the general population: an endoscopic study,” Gastroenterology, vol. 129, no. 6, pp. 1825–1831, 2005.
[16]
D. K. Rex, O. W. Cummings, M. Shaw et al., “Screening of Barrett's esophagus in colonoscopy patients with and without heartburn,” Gastroenterology, vol. 129, pp. 1825–1831, 2005.
[17]
D. Armstrong, J. R. Bennett, A. L. Blum et al., “The endoscopic assessment of esophagitis: a progress report on observer agreement,” Gastroenterology, vol. 111, no. 1, pp. 85–92, 1996.
[18]
L. R. Lundell, J. Dent, J. R. Bennett et al., “Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification,” Gut, vol. 45, no. 2, pp. 172–180, 1999.
[19]
R. E. Sampliner, “Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus,” American Journal of Gastroenterology, vol. 97, no. 8, pp. 1888–1895, 2002.
[20]
A. J. Cameron, A. R. Zinsmeister, D. J. Ballard, and J. A. Carney, “Prevalence of columnar-lined (Barrett's) esophagus: comparison of population-based clinical and autopsy findings,” Gastroenterology, vol. 99, no. 4, pp. 918–922, 1990.
[21]
B. Wallner, A. Sylvan, R. Stenling, and K.-G. Janunger, “The esophageal Z-line appearance correlates to the prevalence of intestinal metaplasia,” Scandinavian Journal of Gastroenterology, vol. 35, no. 1, pp. 17–22, 2000.
[22]
A. Paull, J. S. Trier, and M. D. Dalton, “The histologic spectrum of Barrett's esophagus,” The New England Journal of Medicine, vol. 295, no. 9, pp. 476–480, 1976.
[23]
S. J. Spechler, “The columnar-lined esophagus: history, terminology, and clinical issues,” Gastroenterology Clinics of North America, vol. 26, no. 3, pp. 455–466, 1997.
[24]
M. G. Brandt, G. E. Darling, and L. Miller, “Symptoms, acid exposure and motility in patients with Barrett's esophagus,” Canadian Journal of Surgery, vol. 47, no. 1, pp. 47–51, 2004.
[25]
E. Savarino, R. Tutuian, P. Zentilin et al., “Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy,” American Journal of Gastroenterology, vol. 105, no. 5, pp. 1053–1061, 2010.
[26]
E. J. Ormseth and R. K. H. Wong, “Reflux laryngitis: pathophysiology, diagnosis, and management,” American Journal of Gastroenterology, vol. 94, no. 10, pp. 2812–2817, 1999.
